Search clinical trials for: Faster aspart

Total 10346 results

Mannkind Corporation

Completed

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Diabetes Type 2

Brazil, Spain, United States, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Spectrum Health Hospitals
Helen DeVos Children's Hospital

Completed

The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children

Type 1 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

Diabetes | Diabetes Mellitus, Type 1

Romania
Dennis G. Karounos, M.D.
Novo Nordisk A/S

Completed

Veterans Inpatient Insulin Study and Transition to Outpatient Therapy (VIISTA)

Type 2 Diabetes Mellitus

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject

Diabetes

China
Novo Nordisk A/S

Completed

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes (UPGRADE)

Diabetes Mellitus, Type 2 | Diabetes

Italy
Novo Nordisk A/S

Completed

Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States, Sweden, Norway, Germany, Australia
Novo Nordisk A/S

Completed

Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Canada, Puerto Rico
Novo Nordisk A/S

Completed

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

Healthy | Diabetes

Germany
Seattle Children's Hospital

Completed

Family Assisted Severe Febrile Illness Therapy for Critically-ill Kenyan Children (FASTER)

Critical Illness | Febrile Illness

Kenya
FA Corporation
University of Texas Southwestern Medical Center

Enrolling by invitation

Histological Study of the Effects of a 2910 nm Fiber Laser Technology

Skin Laxity

United States
University of Zurich

Unknown

Effect of Low Level Laser Therapy After Wisdom Tooth Removal

Quality of Life | Wound Heal | Tooth, Impacted

Switzerland
University Hospital, Gentofte, Copenhagen

Unknown

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

Type 2 Diabetes

Denmark
Health Rehab and Research Clinic

Not yet recruiting

The ECEALT Chronic Low Back Pain Study

Chronic Low-back Pain

Canada
University of Aarhus
Aarhus University Hospital

Completed

Bioavailability of Insulin Administered in Duodenum

Diabetes Mellitus

Denmark
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes (TREAD-DIAB)

Type 1 Diabetes

Belgium
Novo Nordisk A/S

Terminated

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States, Canada
Anna Stanhewicz, PhD

Recruiting

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Gestational Diabetes | Vascular Endothelial Function

United States
Novo Nordisk A/S

Completed

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
Sanofi

Completed

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Novo Nordisk A/S

Completed

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Russian Federation, Israel, Croatia, Czech Republic, Slovenia
University of Michigan

Completed

Particulate Matter, Blood Pressure, and the Sympathetic Nervous System (PM-SNS)

Air Pollution

United States
Pfizer

Completed

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Neurogenic Detrusor Overactivity

Belgium
Novo Nordisk A/S

Completed

Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany, Austria, South Africa
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Sweden, Finland, France, Norway
Sanofi

Completed

Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Albert Einstein College of Medicine
National Institute on Aging (NIA)

Completed

Cardiac Surgery Neuroprotection Study in Elders (CNS-Elders)

Post-operative Delirium | Post-operative Cognitive Decline

United States
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Diabetes Mellitus, Type 2 | Diabetes

Turkey
Duke University
National Institute on Drug Abuse (NIDA); Intelligent Automation, Inc.

Unknown

Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence (mSMART-Ib)

Nicotine Dependence

United States
Corcept Therapeutics

Completed

A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects

Healthy

United States
Novo Nordisk A/S

Completed

Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

Diabetes Mellitus, Type 2 | Diabetes

United States
Medical University of Warsaw

Unknown

Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

Diabetes type1

Poland
Region Örebro County
Uppsala-Örebro Regional Research Council

Completed

Treatment of Impaired Glucose Tolerance in Pregnancy (TIP)

Impaired Glucose Tolerance | Fetal Macrosomia

Sweden
Manchester University NHS Foundation Trust
Novo Nordisk A/S

Completed

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart (AP-MFT-01)

Diabetes Mellitus, Type 1

United Kingdom
Huashan Hospital

Recruiting

Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes

Liver Cirrhosis | Diabetes

China
Halozyme Therapeutics

Completed

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes Mellitus

United States
Medical University of Vienna

Completed

Efficiency of Continuous Glucose Monitoring in Critically Ill Patients

Critical Illness

Austria
National Institute of Neurosciences and Hospital...

Completed

Insulin for Hyperglycemia in Stroke Trial

Hyperglycemia | Stroke, Acute

Bangladesh
Novo Nordisk A/S

Completed

Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Australia
University of Florida
Sanofi

Completed

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

Type 1 Diabetes

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR) (CASPAR)

Substance Abuse

United States
Sanofi

Completed

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (SWITCH)

Type 2 Diabetes Mellitus

China
University of Florida
National Institute on Drug Abuse (NIDA)

Recruiting

Smoking Prevention Through Social Connections Among Adolescents - ASPIRE

Tobacco Use Behavior

United States
Centre Hospitalier Intercommunal Creteil

Completed

Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic (MUCONFIN)

Cystic Fibrosis | Cystic Fibrosis in Children

France
University of Novi Sad, Faculty of Sport and Physical...

Completed

Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS) (CREGAAS)

Sarcopenia

Serbia
University Hospital, Brest

Completed

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump (BOLUS)

Diabetes Type 1

France
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL

Urolithiasis | Overactive Bladder Syndrome

China

3

Subscribe